Information:
Error:
ID
29021
Description
Study part: Data Verification (Month 24). A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
Versions (1)
- 2/20/18 2/20/18 -
Copyright Holder
Roche
Uploaded on
February 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Data Verification (Month 24) rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Data Verification (Month 24)
- StudyEvent: ODM
Similar models
Data Verification (Month 24)
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Data Verification
Item
I have reviewed the case report forms and find the data to be complete and accurate.
boolean
C4086865 (UMLS CUI [1])
Investigator
Item
Investigator
text
C2346576 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])